MEDVi vs Ivim Health 2026
Two compounded GLP-1 programs with distinct strengths. MEDVi wins on verified pricing ($179/mo confirmed) and brand trust (33K monthly searches). Ivim Health wins on customization — their microdosing protocols are purpose-built for patients who struggled with standard GLP-1 titration.
At a Glance
MEDVi
Editor’s PickBest for: lowest verified price + highest brand trust
MEDVi has the highest organic brand-search volume of any provider in our stack (33K monthly) and Gronk-verified pricing starting at $179/mo. Standard physician-supervised protocol covering semaglutide and tirzepatide.
- Semaglutide from $179/mo (Gronk-verified)
- Tirzepatide $229–$299/mo (Gronk-verified)
- 33,000 monthly brand searches — largest patient base signal
- Cancel anytime, physician-supervised
Ivim Health
Microdosing SpecialistBest for: custom protocols, prior GI side effects
Ivim Health is built around individualized titration — including microdosing protocols for patients who struggled with standard GLP-1 programs. Pricing requires direct verification at ivimhealth.com.
- Microdosing and customized titration — core clinical differentiator
- Protocol adapts to your tolerance, not a fixed calendar
- Physician-supervised program
- Pricing requires direct verification
Full Side-by-Side
MEDVi data Gronk-verified May 2026. Ivim Health cells marked VERIFY require direct confirmation at ivimhealth.com.
| Dimension | MEDVi | Ivim Health |
|---|---|---|
| Compounded Semaglutide — entry price | $179/mo (range $179–$249/mo) | VERIFY (program fee ~$74.99 + med ~$75+/mo, unconfirmed) |
| Compounded Tirzepatide | $229–$299/mo (Gronk-verified) | VERIFY (availability not confirmed) |
| Metabolic bloodwork included | Not included | VERIFY |
| Titration protocol | Standard schedule (fixed dose escalation) | Individualized — adapts to patient tolerance |
| Microdosing option | Not advertised | Yes — core clinical differentiator |
| Best patient fit | Standard first-time GLP-1 patients, price-sensitive | Patients with prior GI side effects / need custom protocol |
| Physician consult included | Yes | Yes |
| Cancel anytime | Yes | VERIFY |
| Brand search volume (Ahrefs) | ~33,000/mo on "medvi" — highest in our stack | Moderate (specific volume data pending) |
| Affiliate program status | Pending Katalys (offer #1265, $228 CPA) | Not publicly listed (direct outreach pending) |
| Pricing verification | Gronk-verified May 2026 | NOT VERIFIED — check ivimhealth.com directly |
What Ivim Health’s Microdosing Model Actually Does
Standard compounded semaglutide protocols begin at 0.25mg weekly and escalate over 16–24 weeks to maintenance doses up to 2.4mg. This works for most patients, but a meaningful subset — estimates range 15–30% — discontinue early due to nausea, vomiting, or GI discomfort at the standard starting dose.
Ivim Health’s microdosing approach begins at sub-therapeutic doses (often as low as 0.05mg) and titrates upward only when the patient tolerates the current dose without significant side effects. The process is slower — 6–12 months to reach therapeutic doses in some cases — but produces significantly better tolerability for GI-sensitive patients.
MEDVi uses a standard titration model and does not advertise a microdosing option. For most first-time GLP-1 patients with no GI side-effect history, the standard schedule works well. The customization Ivim offers is a specialist service — not necessary for everyone, but meaningfully better for the right patient.
Who should consider Ivim’s model?
- Patients who stopped a prior GLP-1 program specifically due to nausea or vomiting on standard starting doses
- Patients with diagnosed GI conditions (IBS, gastroparesis, GERD) who are concerned about tolerability
- Patients on other medications that affect GI motility
- Older adults or lower-weight patients where standard doses may feel disproportionately strong
- Anyone who wants a conservative, patient-paced onboarding to GLP-1 therapy
Not medical advice. Discuss titration approach with a licensed provider who has reviewed your full medical history.
MEDVi Pricing — Verified
Compounded Semaglutide
$179/mo
$179–$249/mo
Verified on Gronk May 6, 2026Compounded Tirzepatide
$229–$299/mo
Verified on Gronk May 6, 2026Ivim Health pricing: what we know and don’t know
Our data includes a program fee (~$74.99) and a monthly medication component (~$75+/mo), suggesting a total that may be competitive with MEDVi at lower dose tiers. However, these numbers have not been confirmed via a live crawl or Gronk, and the pricing structure (separate fee vs. all-in monthly) differs from MEDVi’s flat monthly model, making direct comparison difficult. Visit ivimhealth.com, complete their intake, and get a personalized quote before comparing.
Who Should Pick Which?
Pick MEDVi if:
- You are starting a GLP-1 program for the first time and have no prior GI side-effect history — MEDVi’s standard protocol is appropriate.
- You want verified, transparent pricing before starting an intake. MEDVi’s $179/mo is Gronk-confirmed and published.
- You want the provider with the strongest brand trust signal (33K monthly searches) and the lowest mid-tier entry price.
- You want both semaglutide and tirzepatide available on one platform.
Consider Ivim Health if:
- You previously discontinued a GLP-1 program specifically because of nausea or vomiting — Ivim’s microdosing model is designed for exactly this patient.
- You want a provider that adapts the titration protocol to your individual tolerance rather than following a fixed schedule.
- You are willing to complete Ivim’s intake to get a verified price quote before making a final decision.
Our Verdict
MEDVi is our editorial pick for this comparison. Gronk-verified pricing from $179/mo, the highest brand search volume in our stack (33K monthly), and a complete mid-tier program covering semaglutide and tirzepatide. For the majority of GLP-1 patients — those starting for the first time without a prior side-effect history — MEDVi is the clean, enrollable choice.
Ivim Health is the specialist pick for the right patient. If you have tried a standard GLP-1 program and discontinued due to GI side effects, or if you have medical factors that make standard titration risky, Ivim’s customized microdosing model is genuinely differentiated. The pricing uncertainty is the only friction — contact them directly to get a quote, then compare it against MEDVi’s $179/mo.
These are complementary programs for different patient profiles — not a quality-vs-quality decision. The editorial pick defaults to verified pricing and immediate enrollability.
Frequently Asked Questions
Which is cheaper, MEDVi or Ivim Health?
MEDVi is the only provider in this comparison with confirmed pricing. MEDVi compounded semaglutide starts at $179/mo (full range $179–$249/mo, Gronk-verified May 2026) and tirzepatide runs $229–$299/mo. Ivim Health pricing is not confirmed through our verification process — their site shows a program fee (~$74.99) plus a monthly medication cost (~$75+/mo), but this data has not been confirmed via a live crawl or Gronk. Visit ivimhealth.com directly to get a personalized quote, then compare it against MEDVi's confirmed $179/mo entry rate.
Is MEDVi or Ivim Health better for tirzepatide?
MEDVi offers compounded tirzepatide at $229–$299/mo (Gronk-verified). Ivim Health's tirzepatide availability and pricing require direct verification — we do not have confirmed data as of May 2026. From a clinical standpoint: MEDVi delivers tirzepatide on a standard titration schedule; Ivim Health customizes the titration protocol to individual patient tolerance. If you are starting tirzepatide for the first time and are not concerned about GI side effects, MEDVi's verified pricing is the cleaner choice. If you have a history of GI side effects on GLP-1 medications, Ivim's customized titration approach is worth investigating despite the pricing uncertainty.
What does Ivim Health's microdosing specialize in?
Ivim Health specializes in individualized GLP-1 titration protocols — including microdosing, which starts patients at sub-therapeutic doses (well below the standard 0.25mg semaglutide starting dose) and titrates upward based on individual tolerance rather than a fixed calendar schedule. This approach is designed for patients who discontinued or struggled with standard compounded GLP-1 programs due to nausea, vomiting, or GI distress. The tradeoff is a longer ramp-up timeline to therapeutic doses (sometimes 6–12 months) in exchange for significantly better tolerability. MEDVi does not advertise a microdosing or custom titration model.
Does MEDVi or Ivim Health include bloodwork?
MEDVi does not include labs in its standard pricing — this is consistent with most mid-tier compounded GLP-1 programs. Ivim Health's lab policy requires direct verification. If metabolic bloodwork as a program inclusion is a priority, Eden Health is a verified option that explicitly includes a comprehensive metabolic panel at $229–$249/mo for semaglutide (see our Eden Health comparisons for detail).
Why is MEDVi the editorial pick over Ivim Health?
MEDVi is our editorial pick in this comparison for two specific reasons: verified pricing and brand trust. MEDVi's $179–$299/mo range is Gronk-verified, and the program carries the highest organic brand search volume of any provider in our stack (33,000 monthly searches on "medvi"). Ivim Health's clinical model — customized microdosing — is genuinely differentiated and valuable for the right patient, but without confirmed pricing we cannot endorse it with equal specificity. This is not a quality judgment; it is a data availability judgment. Ivim Health may be the right fit for patients with prior GI side-effect history. The editorial pick defaults to the verified-pricing option.
Can I use MEDVi now and switch to Ivim Health later if I have side effects?
Yes — telehealth GLP-1 programs do not require long-term commitments and most allow cancellation at any time (MEDVi explicitly allows this). If you start MEDVi and experience intolerable GI side effects on the standard titration schedule, contacting Ivim Health about their microdosing protocols would be a logical next step. Patients who need customized titration often discover this after experiencing side effects on a standard program. MEDVi is a solid starting point if you have no prior GI side-effect history; Ivim Health is the specialist option if standard protocols have failed you. Confirm cancellation and transition terms directly with each provider before enrolling.
Related comparisons
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.